Albendazol STELLA 400 mg

OTC

Indications:

• Single or mixed infections caused by intestinal parasites, such as Ascaris lumbricoides, Enterobius vermicularis, Ancylostoma duodenale, Necator americanus, Trichuris trichiura, Strongyloides stercoralis, Hymenolepis nana, Taenia solium, Taenia saginata, Opisthorchis viverrini and Opisthorchis sinensis.
• Albendazole may be effective against cutaneous larva migrans. Limited data indicate that albendazole is useful in neurocysticercosis. Albendazole seems to be the drug of choice for the treatment of inoperable hydatid cases, but its long-term benefit needs further assessment.

Dosage:

Ascariasis, enterobiasis, ancylostomiasis or trichuriasis:

• Adults and children over 2 years: a single dose of 400 mg. A further dose may be required after 3 weeks.
• Children up to 2 years: A single dose of 200 mg. A further dose may be required after 3 weeks.

Cutaneous larva migrans:

• Adults: 400 mg once daily, for 3 days.
• Children: 5 mg/kg daily, by mouth, for 3 days.

Hydatid disease:

• Adults: 800 mg daily in 2 divided doses with meals for 28 days. Doses may be repeated after 2-3 weeks, up to 2-3 courses, if needed. If hydatid cyst is inoperable, the 28-day course may be repeated after 2-3 weeks up to total of 5 treatment cycles.
• Children over 6 years: 10-15 mg/kg daily for 28 days. Doses may be repeated, if needed.

Neurocysticercosis:

• Adults and children: 15 mg/kg daily for 30 days. Doses may be repeated after 3 weeks.

Taeniasis or H. nana infection, strongyloidiasis:

• Adults and children over 2 years: 400 mg daily in a single dose for 3 days. Doses may be repeated after 3 weeks.
• Children up to 2 years: 200 mg daily in a single dose by mouth for 3 days. Doses may be repeated after 3 weeks.

Usage:

The tablets may be chewed and drunk with a glass of water, or crushed and mixed with food. No special procedures, e.g. fasting or purging are required.

• Patients with a history of hypersensitivity to the compounds of benzimidazole class or any components of the drug.
• Patient with a history of bone marrow toxicity.
• Pregnant women.

Common: Fever; headache, vertigo, meningeal signs, raised intracranial pressure; abnormal functions; abdominal pain, nausea, vomiting; alopecia (reversible).

• Extreme caution should be exercised when use Albendazole STELLA 400 mg for patients with abnormal liver function and Patients with hematological diseases.
• Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.
• Albendazole STELLA 400 mg contains aspartame. Aspartame is a source of phenylalanine. It may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly.
• Albendazole should not be used in pregnant women except in clinical circumstances where no alternative management is appropriate. Patients should not become pregnant for at least 1 months following cessation of albendazole therapy. If pregnancy occurs while taking this drug, the patient should be apprised of the potential hazard to the fetus and albendazole should be discontinued immediately. Caution should be excreted when albendazole is administered to a nursing woman.
• Patients should be aware of how they react to Albendazole STELLA 400 mg before driving or operating machinery.